[go: up one dir, main page]

NL2001552A1 - Rage-fusie-eiwitten, preparaten en werkwijzen voor het gebruik ervan. - Google Patents

Rage-fusie-eiwitten, preparaten en werkwijzen voor het gebruik ervan.

Info

Publication number
NL2001552A1
NL2001552A1 NL2001552A NL2001552A NL2001552A1 NL 2001552 A1 NL2001552 A1 NL 2001552A1 NL 2001552 A NL2001552 A NL 2001552A NL 2001552 A NL2001552 A NL 2001552A NL 2001552 A1 NL2001552 A1 NL 2001552A1
Authority
NL
Netherlands
Prior art keywords
preparations
methods
fusion proteins
rage fusion
rage
Prior art date
Application number
NL2001552A
Other languages
English (en)
Other versions
NL2001552C2 (nl
Inventor
Adnan M M Mjalli
Robert Rothlein
Ye Edward Tian
Jeffrey C Webster
Eric J Benjamin
Original Assignee
Transtech Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transtech Pharma filed Critical Transtech Pharma
Priority to NL2001552A priority Critical patent/NL2001552C2/nl
Publication of NL2001552A1 publication Critical patent/NL2001552A1/nl
Application granted granted Critical
Publication of NL2001552C2 publication Critical patent/NL2001552C2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NL2001552A 2008-05-06 2008-05-06 Rage-fusie-eiwitten, preparaten en werkwijzen voor het gebruik ervan. NL2001552C2 (nl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL2001552A NL2001552C2 (nl) 2008-05-06 2008-05-06 Rage-fusie-eiwitten, preparaten en werkwijzen voor het gebruik ervan.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2001552A NL2001552C2 (nl) 2008-05-06 2008-05-06 Rage-fusie-eiwitten, preparaten en werkwijzen voor het gebruik ervan.
NL2001552 2008-05-06

Publications (2)

Publication Number Publication Date
NL2001552A1 true NL2001552A1 (nl) 2008-12-08
NL2001552C2 NL2001552C2 (nl) 2009-05-07

Family

ID=40329339

Family Applications (1)

Application Number Title Priority Date Filing Date
NL2001552A NL2001552C2 (nl) 2008-05-06 2008-05-06 Rage-fusie-eiwitten, preparaten en werkwijzen voor het gebruik ervan.

Country Status (1)

Country Link
NL (1) NL2001552C2 (nl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090060925A1 (en) * 2004-08-03 2009-03-05 The Trustees Of Columbia University In The City Of Rage Fusion Proteins and Methods of Use
AP2007003869A0 (en) * 2004-08-03 2007-02-28 Transtech Pharma Inc Rage fusion proteins and methods of use
EP1989227A2 (en) * 2006-02-09 2008-11-12 Transtech Pharma, Inc. Rage fusion proteins and methods of use

Also Published As

Publication number Publication date
NL2001552C2 (nl) 2009-05-07

Similar Documents

Publication Publication Date Title
NL2000626A1 (nl) Rage-fusie-eiwitten, preparaten en werkwijzen voor het gebruik ervan.
NL2000476A1 (nl) Rage-fusie-eiwitten en werkwijzen voor het gebruik ervan.
HUS2100038I1 (hu) Anti-CD20 antitest készítmények
LTC2307454I2 (lt) Stabilūs ir tirpūs antikūnai, slopinantys VEGF
BRPI0813452A2 (pt) protéinas de fusão rage.
BRPI0918947A2 (pt) proteína de fusão de anticorpo
BRPI1008740A2 (pt) Proteínas pesticidas e métodos para seu uso.
LTC2358756I2 (lt) Žmogaus antikūnai, pasižymintys dideliu giminingumu pcsk9
LT3287525T (lt) Rnr preparatai, apimantys išgrynintą modifikuotą rnr, skirti ląstelių reprogramavimui
BRPI0813216A2 (pt) Inibidores de proteínas cinases e métodos para usá-los.
ATE524493T1 (de) Exendin-fusionsproteine
BRPI0716744A2 (pt) proteínas de fusão de albumina
BRPI1011760A2 (pt) método para prevenir ou reduzir coagulação no trato gastrointestinal superior de um indivíduo, e, uso de proteína anticoagulante.
BRPI0807480A2 (pt) Ligando, imunoglobulina g, composição e proteína de fusão
PL2942355T3 (pl) Nie-hemolityczne białka fuzyjne llo i ich zastosowanie
HRP20150241T1 (xx) Antikancerogeni fuzijski protein
DK2209375T3 (da) Parp-inhibitorforbindelser, præparater og fremgangsmåder til anvendelse deraf
DK2139987T3 (da) Fremgangsmåder til proteinfremstilling med anti-senescens-forbindelser
DK2064334T3 (da) Aldehydtags, anvendelser deraf i site-specifik proteinmodificering
IL205705A (en) Anti-influenza antibodies, compositions comprising the same and uses thereof
BR112013022285A2 (pt) proteína de fusão de fgfr-fc e o seu uso
DK1976884T3 (da) Anti-ephrinb2-antistoffer og fremgangsmåder til anvendelse deraf.
FR2919373B1 (fr) Raccord rapide perfectionne.
BRPI0923402A2 (pt) Peptídeos c10rf59 e vacinas incluindo os mesmos.
HRP20150021T1 (xx) Spojevi fenantrenona, pripravci i postupci

Legal Events

Date Code Title Description
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20090303

PD2B A search report has been drawn up
V1 Lapsed because of non-payment of the annual fee

Effective date: 20101201